{"id":"https://openalex.org/W7127055301","doi":"https://doi.org/10.1158/0008-5472.31228647","title":"Supplementary Figure 7 from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer","display_name":"Supplementary Figure 7 from Tumor-Associated Macrophages Produce PGE2 to Promote CD8+ T-cell Exhaustion and Drive Resistance to PD-L1 Blockade in Microsatellite-Stable Colorectal Cancer","publication_year":2026,"publication_date":"2026-02-02","ids":{"openalex":"https://openalex.org/W7127055301","doi":"https://doi.org/10.1158/0008-5472.31228647"},"language":null,"primary_location":{"id":"doi:10.1158/0008-5472.31228647","doi":"https://doi.org/10.1158/0008-5472.31228647","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.31228647","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.31228647","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016814827","display_name":"Jean-David Fumet","orcid":"https://orcid.org/0000-0002-9444-941X","observed_orcids":["https://orcid.org/0000-0002-9444-941X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-David Fumet","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9444-941X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124732219","display_name":"Charl\u00e8ne Latour","orcid":"https://orcid.org/0009-0004-5925-7748","observed_orcids":["https://orcid.org/0009-0004-5925-7748"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charl\u00e8ne Latour","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-5925-7748","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077546174","display_name":"Lisa Nuttin","orcid":"https://orcid.org/0009-0002-2634-4787","observed_orcids":["https://orcid.org/0009-0002-2634-4787"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa Nuttin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-2634-4787","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124700538","display_name":"Valentin Derang\u00e8re","orcid":"https://orcid.org/0000-0002-6311-5628","observed_orcids":["https://orcid.org/0000-0002-6311-5628"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valentin Derang\u00e8re","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6311-5628","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124697700","display_name":"Alis Ilie","orcid":"https://orcid.org/0009-0009-5788-1586","observed_orcids":["https://orcid.org/0009-0009-5788-1586"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alis Ilie","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-5788-1586","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124729961","display_name":"Pauline Russo","orcid":"https://orcid.org/0009-0002-0656-5662","observed_orcids":["https://orcid.org/0009-0002-0656-5662"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pauline Russo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-0656-5662","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073726846","display_name":"L\u00e9a Hampe","orcid":"https://orcid.org/0009-0005-5996-6306","observed_orcids":["https://orcid.org/0009-0005-5996-6306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L\u00e9a Hampe","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-5996-6306","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124729692","display_name":"Susy Daumoine","orcid":"https://orcid.org/0009-0003-9585-653X","observed_orcids":["https://orcid.org/0009-0003-9585-653X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susy Daumoine","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-9585-653X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085250039","display_name":"Marion Thibaudin","orcid":"https://orcid.org/0000-0002-1046-5982","observed_orcids":["https://orcid.org/0000-0002-1046-5982"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marion Thibaudin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1046-5982","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011315376","display_name":"Caroline Truntzer","orcid":"https://orcid.org/0000-0003-0895-4813","observed_orcids":["https://orcid.org/0000-0003-0895-4813"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline Truntzer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0895-4813","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043463827","display_name":"Fran\u00e7ois Ghiringhelli","orcid":"https://orcid.org/0000-0002-5465-8305","observed_orcids":["https://orcid.org/0000-0002-5465-8305","https://orcid.org/0009-0000-3637-9479"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francois Ghiringhelli","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5465-8305","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5018585640","display_name":"Emeric Limagne","orcid":"https://orcid.org/0000-0002-1098-8441","observed_orcids":["https://orcid.org/0000-0002-1098-8441"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emeric Limagne","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1098-8441","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.888700008392334,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.888700008392334,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.1046999990940094,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.996999979019165},{"id":"https://openalex.org/keywords/prostaglandin-e2","display_name":"prostaglandin E2","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cd8-t-cell-exhaustion","display_name":"CD8+ T cell exhaustion","score":0.9879999756813049},{"id":"https://openalex.org/keywords/microsatellite-stable-colorectal-cancer","display_name":"microsatellite stable colorectal cancer","score":0.9539999961853027},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.9539999961853027},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.8999999761581421},{"id":"https://openalex.org/keywords/ct26-tumor-model","display_name":"CT26 tumor model","score":0.6940000057220459},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6610000133514404}],"concepts":[{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.8544999957084656},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7820000052452087},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6463000178337097},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5605999827384949},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.45010000467300415},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.44690001010894775},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3765000104904175},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.32839998602867126},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.29820001125335693},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.29159998893737793},{"id":"https://openalex.org/C2777956040","wikidata":"https://www.wikidata.org/wiki/Q416554","display_name":"Prostaglandin E2","level":2,"score":0.28949999809265137},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2766999900341034},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2745000123977661},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.267300009727478}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.31228647","doi":"https://doi.org/10.1158/0008-5472.31228647","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.31228647","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.31228647","doi":"https://doi.org/10.1158/0008-5472.31228647","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.31228647","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6054965853691101}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"CT26":[0],"tumor":[1],"bearing":[2],"mice":[3],"were":[4],"treated":[5],"or":[6,15],"not":[7,16],"with":[8,17],"celecoxib":[9],"+":[10],"E2/E4":[11],"inhibitor":[12],"in":[13],"combination":[14],"anti-PD-L1":[18],"antibody":[19]},"counts_by_year":[],"updated_date":"2026-10-06T10:28:23.643775","created_date":"2026-02-03T00:00:00"}